News|Articles|March 2, 2005
- Pharmaceutical Technology-03-02-2005
- Volume 29
- Issue 3
A “Disclosure Defense” in Liability Law
In this time of liability reform, pharma deserves the chance to align its economic interests with its ethical obligations to the patient.
Advertisement
Articles in this issue
over 20 years ago
March 2005over 20 years ago
Packaging Becomes Part of the Prescriptionover 20 years ago
Appraisal of the Laser Diffraction Particle-Sizing Techniqueover 20 years ago
Optimism Taking Over in Pharmaceutical Chemicalsover 20 years ago
In the Spotlight - March 2005over 20 years ago
Managing Aseptic Interventionsover 20 years ago
Validating Automated Systemsover 20 years ago
Combination Products Raise Manufacturing ChallengesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
2
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
3
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
4
AAPS PharmSci 360 2025: Trends in Bioanalysis
5
